The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

A. von Eckardstein

Institut für Klinische Chemie und Laboratoriumsmedizin


Westfälische Wilhelms-Universität Münster



Name/email consistency: high



  • Institut für Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Westfälische Wilhelms-Universität Münster, Germany. 1998 - 2001
  • Institut für Arterioskleroseforschung an der Universität Münster, Germany. 1998


  1. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. von Eckardstein, A., Nofer, J.R., Assmann, G. Arterioscler. Thromb. Vasc. Biol. (2001) [Pubmed]
  2. Clinical implications of elevated lipoprotein(a). von Eckardstein, A., Assmann, G. Curr. Atheroscler. Rep (2001) [Pubmed]
  3. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. Von Eckardstein, A., Langer, C., Engel, T., Schaukal, I., Cignarella, A., Reinhardt, J., Lorkowski, S., Li, Z., Zhou, X., Cullen, P., Assmann, G. FASEB J. (2001) [Pubmed]
  4. Association of serum apolipoprotein A-I (but not high-density lipoprotein cholesterol) with healed myocardial infarction in men independent of serum insulin and C-peptide. von Eckardstein, A., Fischer, F., Schulte, H., Tataru, M., Köhler, E., Assmann, G. Am. J. Cardiol. (2001) [Pubmed]
  5. Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity. von Eckardstein, A., Schmiddem, K., Hövels, A., Gülbahçe, E., Schuler-Lüttmann, S., Elbers, J., Helmond, F., Bennink, H.J., Assmann, G. Atherosclerosis (2001) [Pubmed]
  6. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster. von Eckardstein, A., Schulte, H., Assmann, G. J. Clin. Endocrinol. Metab. (2000) [Pubmed]
  7. Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?. von Eckardstein, A., Assmann, G. Curr. Opin. Lipidol. (2000) [Pubmed]
  8. Acceleration of reverse cholesterol transport. von Eckardstein, A., Nofer, J.R., Assmann, G. Curr. Opin. Cardiol. (2000) [Pubmed]
  9. Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients. von Eckardstein, A., Huang, Y., Kastelein, J.J., Geisel, J., Real, J.T., Kuivenhoven, J.A., Miccoli, R., Noseda, G., Assmann, G. Atherosclerosis (1998) [Pubmed]
  10. High density lipoproteins and reverse cholesterol transport: lessons from mutations. von Eckardstein, A., Assmann, G. Atherosclerosis (1998) [Pubmed]
WikiGenes - Universities